199 related articles for article (PubMed ID: 37265694)
21. Castleman Disease: A Multicenter Case Series from Turkey.
Gündüz E; Kırkızlar HO; Ümit EG; Karaman Gülsaran S; Özkocaman V; Özkalemkaş F; Candar Ö; Elverdi T; Küçükyurt S; Paydaş S; Çeneli Ö; Karakuş S; Maral S; Ekinci Ö; İpek Y; Kis C; Güven ZT; Akdeniz A; Celkan T; Eroğlu Küçükdiler AH; Akgün Çağlıyan G; Özçelik Şengöz C; Karataş A; Bulduk T; Özcan A; Belen Apak FB; Canbolat A; Kartal İ; Ören H; Töret E; Özdemir GN; Bakanay Öztürk ŞM
Turk J Haematol; 2022 Jun; 39(2):130-135. PubMed ID: 35176839
[TBL] [Abstract][Full Text] [Related]
22. [Clinical analysis of 25 patients with bilateral pheochromocytomas].
Tong AL; Zeng ZP; Yang D; Li HZ; Li M
Zhonghua Nei Ke Za Zhi; 2005 Oct; 44(10):751-4. PubMed ID: 16255883
[TBL] [Abstract][Full Text] [Related]
23. Unicentric castleman disease located in the left popliteal fossa: a case report.
Lv H; Zhao H
BMC Musculoskelet Disord; 2022 Mar; 23(1):278. PubMed ID: 35321668
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies.
Menke DM; Tiemann M; Camoriano JK; Chang SF; Madan A; Chow M; Habermann TM; Parwaresch R
Am J Clin Pathol; 1996 Mar; 105(3):268-76. PubMed ID: 8602606
[TBL] [Abstract][Full Text] [Related]
25. Classic Hodgkin lymphoma and Castleman disease: an entity appears to be emerging.
Lyapichev KA; You MJ; Vega F; Solis LM; Medeiros LJ
Virchows Arch; 2020 Sep; 477(3):437-444. PubMed ID: 32152665
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous involvement as initial presentation of multicentric plasmacytic Castleman disease.
Chen H; Ba W; Chen H; Yang H
J Cutan Pathol; 2021 May; 48(5):701-705. PubMed ID: 33469928
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive analysis of 225 Castleman's diseases in the oral maxillofacial and neck region: a rare disease revisited.
He X; Wang Q; Wu Y; Hu J; Wang D; Qi B; Zhang W; Wang Y; Cheng J
Clin Oral Investig; 2018 Apr; 22(3):1285-1295. PubMed ID: 28980074
[TBL] [Abstract][Full Text] [Related]
28. Atypical lymphoproliferative disorders: Castleman's disease. Case report and review of the literature.
Martino G; Cariati S; Tintisona O; Veneroso S; De Villa F; Vergine M; Monti M
Tumori; 2004; 90(3):352-5. PubMed ID: 15315321
[TBL] [Abstract][Full Text] [Related]
29. A pheochromocytoma case diagnosed as adrenal incidentaloma.
Vurallı D; Kandemir N; Clark G; Orhan D; Alikaşifoğlu A; Gönç N; Ekinci S; Özön A
Turk J Pediatr; 2017; 59(2):200-206. PubMed ID: 29276876
[TBL] [Abstract][Full Text] [Related]
30. [The diagnosis and management of adrenal "incidentaloma"].
Chao CS; Zhou ZG; Liao EY
Zhonghua Nei Ke Za Zhi; 1994 Jun; 33(6):395-7. PubMed ID: 7867431
[TBL] [Abstract][Full Text] [Related]
31. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy.
Chronowski GM; Ha CS; Wilder RB; Cabanillas F; Manning J; Cox JD
Cancer; 2001 Aug; 92(3):670-6. PubMed ID: 11505414
[TBL] [Abstract][Full Text] [Related]
32. A rare disease with pregnancy: Castleman case report.
Karaman ÖE; Kılıççı Ç; Önder PÖ
Malawi Med J; 2021 Dec; 33(4):300-302. PubMed ID: 35291389
[TBL] [Abstract][Full Text] [Related]
33. Castleman disease versus lymphoma in neck lymph nodes: a comparative study using contrast-enhanced CT.
Li J; Wang J; Yang Z; Wang H; Che J; Xu W
Cancer Imaging; 2018 Aug; 18(1):28. PubMed ID: 30115111
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous adrenal pheochromocytoma and sarcoidosis.
Kim KA; Kim SW; Park G; Kwak BS; Choi JS; Kim SH; Yeo JS; Kim EJ
South Med J; 2009 May; 102(5):537-41. PubMed ID: 19373144
[TBL] [Abstract][Full Text] [Related]
35. Follicular lymphoma with hyaline-vascular Castleman-like features: analysis of 6 cases and review of the literature.
Pina-Oviedo S; Miranda RN; Lin P; Manning JT; Medeiros LJ
Hum Pathol; 2017 Oct; 68():136-146. PubMed ID: 28873356
[TBL] [Abstract][Full Text] [Related]
36. Hyaline-vascular castleman disease: a rare cause of solitary subcutaneous soft tissue mass.
Naghashpour M; Cualing HD; Szabunio M; Bui MM
Am J Dermatopathol; 2010 May; 32(3):293-297. PubMed ID: 20098298
[TBL] [Abstract][Full Text] [Related]
37. [Non-secreting pheochromocytoma of the broad ligament revealed by appendicular peritonitis].
Alamowitch B; Mausset V; Ruiz A; Tissier F; Fourmestraux J; Bouillot JL; Bethoux JP
Presse Med; 1999 Feb; 28(5):225-8. PubMed ID: 10076596
[TBL] [Abstract][Full Text] [Related]
38. Malignant pheochromocytoma: clinical course and treatment.
Mahoney EM; Harrison JH
J Urol; 1977 Aug; 118(2):225-9. PubMed ID: 894796
[TBL] [Abstract][Full Text] [Related]
39. Clinical experience over 48 years with pheochromocytoma.
Goldstein RE; O'Neill JA; Holcomb GW; Morgan WM; Neblett WW; Oates JA; Brown N; Nadeau J; Smith B; Page DL; Abumrad NN; Scott HW
Ann Surg; 1999 Jun; 229(6):755-64; discussion 764-6. PubMed ID: 10363888
[TBL] [Abstract][Full Text] [Related]
40. Adrenal incidentalomas: experience from a retrospective study in a Chinese population.
Bin X; Qing Y; Linhui W; Li G; Yinghao S
Urol Oncol; 2011; 29(3):270-4. PubMed ID: 19481963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
